CERLIMA

Manufacturer
Guangzhou Zhongkebaishi Health Industry CO., LTD
Effective date
2026-01-16
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:33:30

Label at a glance#

ProductCERLIMA
Active ingredientBENZALKONIUM BROMIDE
Label structure12 sections

Dosage and administration

After washing your hands, open the package, remove the cap, and applyit to the intimate area. Discard applicator after one application.

Storage and handling

1. Store at 15-30°C(59-86°F) 2. Avoid freezing 3. Protect from direct sunlight and excessive heat above 40°C (104°F)

Label contents#

Full prescribing information#

Active Ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Benzalkonium Bromide 0.09%

Purpose

OTC - PURPOSE SECTION

Antiseptic / Antimicrobial

Use

INDICATIONS & USAGE SECTION

1.Reduce vaginal microorganisms that may cause odor, discomfort, or imbalance

2.Provides gentle intimate care and temporary relief of mild irritation.

3.For intravaginal and external topical use.

Warnings

WARNINGS SECTION

For external and intravaginal use only

Do not use

OTC - DO NOT USE SECTION

1. if you are pregnant or in gestational periods
2. on scars, eczema, or dermatitis
3. if you have a known allergy to Benzalkonium Bromide or any listed ingredients

OTC - WHEN USING SECTION

1. After opening the cap, use the product immediately and do not reuse it.

2. avoid contact with eyes; if contact occurs, rinse thoroughly with water
3. mild temporary tingling may occur
2. do not share applicators

OTC - STOP USE SECTION

1. irritation, rash, red spot or discomfort occurs .

2.abnormal discharge, fever, pelvic pain, or foul odor develops (may be signs ofanother condition requiring medical attention)

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center Immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

After washing your hands, open the package, remove the cap, and applyit to the intimate area. Discard applicator after one application.

Other information

STORAGE AND HANDLING SECTION

1. Store at 15-30°C(59-86°F)
2. Avoid freezing

3. Protect from direct sunlight and excessive heat above 40°C (104°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

1,2-Hexanediol, 1,2-Pentanediol, Betaine, Butylene Glycol, Carbomer,Centella Asiatica Extract, Cnidium Monnieri Extract, Curcumin,Dandelion (Taraxacum Officinale) Extract, Epigallocatechin GallateEGG Grerfar abereIGlee taee'NeovSPerfoY,'SCuferferarin.Baicalensis Root Extract, Tanshinone IA, Triethanolamine.

Package Label - Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

undefinedundefined

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d1c9d1af-bddd-448d-86f7-69052b7d5b47Product name120220627

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73813-0001-1CERLIMA3 g in 1 VIALGEL32
73813-0001-2CERLIMA7 in 1 BOXGEL72

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73813-000173813-0001-1, 73813-0001-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
48816642-2a36-a874-e063-6294a90ab3dd475161ab-d279-142e-e063-6394a90ab13a2026-01-16WarningsExact identifier
spl id: 48816642-2a36-a874-e063-6294a90ab3dd
spl set id: 475161ab-d279-142e-e063-6394a90ab13a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.